This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sader, S. Articles by Liu, P. Search for Related Content PubMed PubMed Citation Articles by Sader, S. Articles by Liu, P. Related Collections Obesity Remodeling Hypertrophy Myocardial cardiomyopathy disease Related Article

(Circulation. 2003;108:644.)
© 2003 American Heart Association, Inc.

Editorial

Leptin

A Novel Link Between Obesity, Diabetes, Cardiovascular Risk, and Ventricular Hypertrophy

Sawsan Sader, PhD; Min Nian, PhD; Peter Liu, MD, FRCPC

From the Heart & Stroke/Richard Lewar Centre of Excellence, and the Department of Physiology, University of Toronto; and Division of Cardiology, Toronto General Hospital, University Health Network, Toronto, Canada.

Correspondence to Dr Peter Liu, Heart & Stroke/RL Centre of Excellence, EN12-324, Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, M5G 2C4, Canada. E-mail peter.liu@utoronto.ca

Key Words: Editorials • hormones • obesity • diabetes mellitus • hypertrophy

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Obesity and associated type 2 diabetes mellitus are the emerging epidemic of this new century. Identifying the key mechanism of the pathophysiology offers unique insights into potential prevention and therapy. One of the classic animal models of obesity and insulin resistance has been the ob/ob mouse. Zhang et al¹ set the scientific world a-buzz in 1994 with the discovery that the obesity (ob) gene product was in fact leptin, and leptin deficiency accounted for the obesity in these mice.

See p 754

Leptin is secreted by the fat cells, along with other tissues, to act on the hypothalamic leptin receptors (Ob-Rb) to decrease food intake and increase energy expenditure in the host.² Under physiological conditions, the amount of leptin produced by fat tissues is directly related to the mass of adipose tissues.³ Both leptin deficiency (ob/ob mice) and leptin resistance (db/db mice having a defective leptin receptor) lead to hyperphagia and decreased energy expenditure in the host (Figure 1). Predictably, this leads to obesity, the insulin resistance type of diabetes, and a decrease in lean body mass.^4,5 Correction of leptin deficiency in the ob/ob mouse causes a marked reduction in food intake and a normalization of its weight.^2,3,6

View larger version (30K): [in this window] [in a new window]   Figure 1. Circles of feedback in primary leptin deficiency. This is the situation found in ob/ob mice, or rare human genetic mutations. In this setting, the adipose tissue will not be able to elaborate leptin commensurate with the fat tissue mass. This leaves the leptin receptor unoccupied. The receptor signals . . . [Full Text of this Article]

Related Article:

Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice

Lili A. Barouch, Dan E. Berkowitz, Robert W. Harrison, Christopher P. O’Donnell, and Joshua M. Hare
Circulation 2003 108: 754-759. [Abstract] [Full Text]

This article has been cited by other articles:

				R. Yang and L. A. Barouch Leptin Signaling and Obesity: Cardiovascular Consequences Circ. Res., September 14, 2007; 101(6): 545 - 559. [Abstract] [Full Text] [PDF]

				M.-H. Gannage-Yared, S. Khalife, M. Semaan, F. Fares, S. Jambart, and G. Halaby Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur. J. Endocrinol., July 1, 2006; 155(1): 167 - 176. [Abstract] [Full Text] [PDF]

				S. Madani, S. De Girolamo, D. M. Munoz, R.-K. Li, and G. Sweeney Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes Cardiovasc Res, February 15, 2006; 69(3): 716 - 725. [Abstract] [Full Text] [PDF]

				S.-Y. Park, Y.-R. Cho, H.-J. Kim, T. Higashimori, C. Danton, M.-K. Lee, A. Dey, B. Rothermel, Y.-B. Kim, A. Kalinowski, et al. Unraveling the Temporal Pattern of Diet-Induced Insulin Resistance in Individual Organs and Cardiac Dysfunction in C57BL/6 Mice Diabetes, December 1, 2005; 54(12): 3530 - 3540. [Abstract] [Full Text] [PDF]

				H. S. Elbatarny and D. H. Maurice Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E695 - E702. [Abstract] [Full Text] [PDF]

				D. Hamerman Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies QJM, July 1, 2005; 98(7): 467 - 484. [Abstract] [Full Text] [PDF]

				K. M. Minhas, S. A. Khan, S. V. Y. Raju, A. C. Phan, D. R. Gonzalez, M. W. Skaf, K. Lee, A. D. Tejani, A. P. Saliaris, L. A. Barouch, et al. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy J. Physiol., June 1, 2005; 565(2): 463 - 474. [Abstract] [Full Text] [PDF]

				A. S.M. Shamsuzzaman, M. Winnicki, R. Wolk, A. Svatikova, B. G. Phillips, D. E. Davison, P. B. Berger, and V. K. Somers Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans Circulation, May 11, 2004; 109(18): 2181 - 2185. [Abstract] [Full Text] [PDF]

				P. Tajmir, R. B. Ceddia, R.-K. Li, I. R. Coe, and G. Sweeney Leptin Increases Cardiomyocyte Hyperplasia via Extracellular Signal-Regulated Kinase- and Phosphatidylinositol 3-Kinase-Dependent Signaling Pathways Endocrinology, April 1, 2004; 145(4): 1550 - 1555. [Abstract] [Full Text] [PDF]